Related Experiment Video
Updated: Feb 11, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
A Quantitative Chemotherapy Genetic Interaction Map Reveals Factors Associated with PARP Inhibitor Resistance
Hsien-Ming Hu1, Xin Zhao1, Swati Kaushik1
1Bioengineering and Therapeutic Sciences, Helen Diller Family Comprehensive Cancer Center and Institute for Computational Health Sciences. University of California, San Francisco, San Francisco, CA 94158, USA.
Abstract:
Chemotherapy is used to treat most cancer patients, yet our understanding of factors that dictate response and resistance to such drugs remains limited. We report the generation of a quantitative chemical-genetic interaction map in human mammary epithelial cells charting the impact of the knockdown of 625 genes related to cancer and DNA repair on sensitivity to 29 drugs, covering all classes of chemotherapy. This quantitative map is predictive of interactions maintained in other cell lines, identifies DNA-repair factors, predicts cancer cell line responses to therapy, and prioritizes synergistic drug combinations. We identify that ARID1A loss confers resistance to PARP inhibitors in cells and ovarian cancer patients and that loss of GPBP1 causes resistance to cisplatin and PARP inhibitors through the regulation of genes involved in homologous recombination. This map helps navigate patient genomic data and optimize chemotherapeutic regimens by delineating factors involved in the response to specific types of DNA damage.
Insights
This study maps gene interactions and chemotherapy drug responses in cancer cells. It identifies genetic factors influencing drug resistance, aiding in personalized cancer treatment strategies.
Area of Science:
- Genomics
- Cancer Biology
- Pharmacology
Background:
- Chemotherapy is a cornerstone of cancer treatment, but patient response and resistance mechanisms are not fully understood.
- Identifying factors that influence drug sensitivity is crucial for optimizing therapeutic outcomes.
Purpose of the Study:
- To create a quantitative map of chemical-genetic interactions in human mammary epithelial cells.
- To understand how gene knockdowns affect sensitivity to various chemotherapy drugs.
- To predict drug responses and identify synergistic drug combinations.
Main Methods:
- Generated a quantitative chemical-genetic interaction map by knocking down 625 cancer and DNA repair genes.
- Assessed the impact of these knockdowns on sensitivity to 29 different chemotherapy drugs.
- Validated predictive interactions in other cell lines.
Main Results:
- The map accurately predicts drug interactions in different cell lines.
- Identified key DNA repair factors influencing chemotherapy response.
- ARID1A loss was linked to PARP inhibitor resistance in cell lines and ovarian cancer patients.
- GPBP1 loss was associated with resistance to cisplatin and PARP inhibitors via homologous recombination pathway regulation.
Conclusions:
- The developed map aids in navigating patient genomic data to optimize chemotherapy regimens.
- It delineates factors involved in the response to specific DNA damage types.
- This approach can help personalize cancer therapy by predicting drug responses and identifying resistance mechanisms.
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Quantitative Aspects of Drug-Receptor Interaction
Genetics of Speciation
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Transcription Factors
Types of Genetic Transfer Between Organisms

